Skip to main content

The Wistar Institute

|

Wistar Scientists Move HIV Vaccine Research Forward by Developing an Immunogen that Produces Tier-2 Antibodies—the Kind That Matter for Combatting HIV

PHILADELPHIA — (Feb. 4, 2022) — Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in canc…
Read more
|

Wistar Scientists Behind the Next Wave of COVID-19 Vaccines

Current COVID-19 vaccines were created in record time, but scientists are working to make better, longer lasting vaccines that could be used around the world. The first generation of COVID-19 vaccines have been highly effective, but also have limi…
Read more
|

Novel Nanoparticle SARS-CoV-2 Vaccine Combines Immune Focusing and Self-assembling Nanoparticles to Elicit More Potent Protection

PHILADELPHIA — (Feb. 1, 2022) — The first generation of COVID-19 vaccines have been highly effective, but also have limitations: their efficacy can wane without a booster shot, and they may be less effective against some variants. Now scientists a…
Read more
|

The Wistar Institute Hosts U.S. Department of Commerce Official Making Major Grant Announcements to Strengthen Workforce Pipelines in Philadelphia & Across the Nation

Wistar is a finalist of the STEM Talent Challenge to create a new life science workforce training program to address Pennsylvania industry growth and demand for skilled workers. U.S. Assistant Secretary of Commerce for Economic Development Alejand…
Read more
|

Wistar Scientists Identify Therapeutic Target for Epstein-Barr Virus

PHILADELPHIA — (Jan. 17, 2022) — A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for develop…
Read more
|

Women & Science Virtual Event: Molecular and Cellular Mechanisms of Itch, Pain and Inflammation

Special Event Thursday, Feb. 17, 2022 5:00 p.m. to 6:00 p.m. Dr. Diana Bautista, Howard Hughes Medical Investigator and Professor of Cell and Developmental Biology at University of California, Berkeley will be discussing how the brain engages with…
Read more
|

The Wistar Institute Is Pleased to Announce the Promotion of Dr. Rahul Shinde to Assistant Professor, and the Promotions of Drs. Mohamed Abdel-Mohsen and Alessandro Gardini to Associate Professor

Wistar is honored these talented and accomplished scientists commit each day in their lab to bringing new and creative insights to cancer, immunology, and infectious disease research. Their original research makes them leaders in their fields and …
Read more
|

Distinguished Lectures in Cancer Research Series: New Directions in Ovarian Cancer Research [Virtual Event]

Scientific Seminar Tuesday, Feb. 22, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of The Wistar Institute Cancer Center and features national and international leaders in basic an…
Read more
|

Distinguished Lectures in Cancer Research Series: Deciphering the Complexity of Cancer Immunity [Virtual Event]

Scientific Seminar Tuesday, Mar. 22, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of The Wistar Institute Cancer Center and features national and international leaders in basic an…
Read more
|

Wistar and Stanford Medicine to Begin Phase 2 Clinical Trial of VK-2019 in Patients with Epstein-Barr Virus (EBV)-Positive Advanced Nasopharyngeal Carcinoma

PHILADELPHIA — (Jan. 5, 2022) — The Wistar Institute announces the initiation of a Phase 2 clinical study of VK-2019 in patients with advanced Epstein-Barr Virus (EBV)-positive nasopharyngeal carcinoma (NPC) and lymphoma. The study, led by researc…
Read more